Therapeutic drug monitoring (TDM) is becoming prevalent in the hospital, especially in the treatment of critically ill patients where pharmacokinetic and pharmacodynamic profiles are compromised due to severe illness. The ability for doctors to evaluate how much active drug is being delivered in real time can enable adaptive treatment options that will result in better patient outcome while reducing risk of drug resistant microorganisms. With AGILE Mx, we plan to offer physicians a global picture of the health of the patient at the bedside in
